Salarius Pharmaceuticals Inc
NASDAQ:SLRX

Watchlist Manager
Salarius Pharmaceuticals Inc Logo
Salarius Pharmaceuticals Inc
NASDAQ:SLRX
Watchlist
Price: 0.6132 USD -2.68% Market Closed
Market Cap: 1.3m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

SLRX Price Targets Summary
Salarius Pharmaceuticals Inc

There are no price targets for SLRX.
SLRX Lowest Forecast
Wall Street Target
Not Available
SLRX Average Forecast
Wall Street Target
Not Available
SLRX Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Salarius Pharmaceuticals Inc Competitors:
Price Targets
300676
BGI Genomics Co Ltd
4% Upside
LTRN
Lantern Pharma Inc.
424% Upside
OPK
OPKO Health Inc
128% Upside
PAR
Paradigm Biopharmaceuticals Ltd
79% Upside
300676
BGI Genomics Co Ltd
4% Upside
LTRN
Lantern Pharma Inc.
424% Upside
OPK
OPKO Health Inc
128% Upside
PAR
Paradigm Biopharmaceuticals Ltd
79% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
5% Upside
ATYR
aTyr Pharma Inc
241% Upside
COV
Covalon Technologies Ltd
48% Upside
002252
Shanghai RAAS Blood Products Co Ltd
3% Upside

Revenue
Forecast

Revenue Estimate
Salarius Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Salarius Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Salarius Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-97%
Average Miss
What are analyst estimates?

See Also

Summary
SLRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
SLRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SLRX stock valuation using valuation multiples.
Wall Street Estimates
SLRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SLRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SLRX's stock price target?
Not Available

SLRX doesn't have any price targets made by Wall Street professionals.

Back to Top
ALPHA SPREAD
Follow us
Join more than 268,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.